171 related articles for article (PubMed ID: 12677560)
1. Inhaled nitric oxide inhibits the release of matrix metalloproteinase-2, but not platelet activation, during extracorporeal membrane oxygenation in adult rabbits.
Cheung PY; Sawicki G; Peliowski A; Etches PC; Schulz R; Radomski MW
J Pediatr Surg; 2003 Apr; 38(4):534-8. PubMed ID: 12677560
[TBL] [Abstract][Full Text] [Related]
2. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates.
Cheung PY; Sawicki G; Salas E; Etches PC; Schulz R; Radomski MW
Crit Care Med; 2000 Jul; 28(7):2584-90. PubMed ID: 10921599
[TBL] [Abstract][Full Text] [Related]
3. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
[TBL] [Abstract][Full Text] [Related]
4. Predictability model of the need for extracorporeal membrane oxygenation in neonates with meconium aspiration syndrome treated with inhaled nitric oxide.
Friedlich P; Noori S; Stein J; Shin C; Burns C; Ramanathan R; Seri I
J Pediatr Surg; 2005 Jul; 40(7):1090-3. PubMed ID: 16034750
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy.
Fakioglu H; Totapally BR; Torbati D; Raszynski A; Sussmane JB; Wolfsdorf J
J Crit Care; 2005 Sep; 20(3):288-93. PubMed ID: 16253800
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2.
Fernandez-Patron C; Martinez-Cuesta MA; Salas E; Sawicki G; Wozniak M; Radomski MW; Davidge ST
Thromb Haemost; 1999 Dec; 82(6):1730-5. PubMed ID: 10613662
[TBL] [Abstract][Full Text] [Related]
7. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.
Falcinelli E; Giannini S; Boschetti E; Gresele P
Br J Haematol; 2007 Jul; 138(2):221-30. PubMed ID: 17593030
[TBL] [Abstract][Full Text] [Related]
8. The effect of inhaled nitric oxide on the course of extracorporeal membrane oxygenation and the occurrence of hemorrhagic complications.
de Mol AC; van Heijst AF; de Haan TF; van der Staak FH; Liem KD
ASAIO J; 2009; 55(3):213-6. PubMed ID: 19293708
[TBL] [Abstract][Full Text] [Related]
9. Risk of need for extracorporeal membrane oxygenation support in neonates with congenital diaphragmatic hernia treated with inhaled nitric oxide.
Sebald M; Friedlich P; Burns C; Stein J; Noori S; Ramanathan R; Seri I
J Perinatol; 2004 Mar; 24(3):143-6. PubMed ID: 14961042
[TBL] [Abstract][Full Text] [Related]
10. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of coagulation related to the use of inhaled nitric oxide before extracorporeal membrane oxygenation.
de Mol AC; van Heijst AF; Brouwers M; de Haan TF; van der Staak FH; Liem KD
Pediatr Crit Care Med; 2007 May; 8(3):261-3. PubMed ID: 17417131
[TBL] [Abstract][Full Text] [Related]
12. Localization and translocation of MMP-2 during aggregation of human platelets.
Sawicki G; Sanders EJ; Salas E; Wozniak M; Rodrigo J; Radomski MW
Thromb Haemost; 1998 Nov; 80(5):836-9. PubMed ID: 9843180
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.
Sheu JR; Fong TH; Liu CM; Shen MY; Chen TL; Chang Y; Lu MS; Hsiao G
Br J Pharmacol; 2004 Sep; 143(1):193-201. PubMed ID: 15289295
[TBL] [Abstract][Full Text] [Related]
14. Protection of platelets during long-term extracorporeal membrane oxygenation in sheep with a single dose of a disintegrin.
Shigeta O; Gluszko P; Downing SW; Lu W; Niewiarowski S; Edmunds LH
Circulation; 1992 Nov; 86(5 Suppl):II398-404. PubMed ID: 1424031
[TBL] [Abstract][Full Text] [Related]
15. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up.
Clark RH; Huckaby JL; Kueser TJ; Walker MW; Southgate WM; Perez JA; Roy BJ; Keszler M;
J Perinatol; 2003 Jun; 23(4):300-3. PubMed ID: 12774137
[TBL] [Abstract][Full Text] [Related]
16. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn.
Hoffman GM; Ross GA; Day SE; Rice TB; Nelin LD
Crit Care Med; 1997 Feb; 25(2):352-9. PubMed ID: 9034276
[TBL] [Abstract][Full Text] [Related]
17. Platelet dysfunction in asphyxiated newborn piglets resuscitated with 21% and 100% oxygen.
Cheung PY; Stevens JP; Haase E; Stang L; Bigam DL; Etches W; Radomski MW
Pediatr Res; 2006 May; 59(5):636-40. PubMed ID: 16627873
[TBL] [Abstract][Full Text] [Related]
18. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
Hoskote AU; Castle RA; Hoo AF; Lum S; Ranganathan SC; Mok QQ; Stocks J
Pediatr Pulmonol; 2008 Mar; 43(3):224-35. PubMed ID: 18203182
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.
Lee YM; Lee JJ; Shen MY; Hsiao G; Sheu JR
Eur J Pharmacol; 2006 May; 537(1-3):52-8. PubMed ID: 16624282
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome.
Gries A; Herr A; Kirsch S; Günther C; Weber S; Szabo G; Holzmann A; Böttiger BW; Martin E
Crit Care Med; 2003 Jun; 31(6):1697-704. PubMed ID: 12794407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
